Todos Medical Completes Trial Design for Tollovid™ Long COVID Clinical Study in Adults
11 août 2022 09h07 HE
|
Todos Medical Ltd.
§ 3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens § Finalizing contracts with two Long COVID clinics to recruit patients § Institutional Review Board (IRB)...
Todos Medical Announces PCR Validation of Wound and Respiratory Pathogen Panels at CLIA/CAP Lab Provista Diagnostics
10 août 2022 09h11 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL , Aug. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,...
Todos Medical Announces First Two Contracts for PCR-based MonkeyPox Testing at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics
08 août 2022 07h25 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Announces First Long COVID Clinic Laboratory Services Agreement for Long COVID Panel Biomarker Partnership with Amerimmune Diagnostics
05 août 2022 13h49 HE
|
Todos Medical Ltd.
RTHM collaborating on Tollovid™ 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function claims in Long COVID New York, NY, and...
Todos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics
03 août 2022 07h52 HE
|
Todos Medical Ltd.
§ Lesion swab (standard of care) and saliva-based sample collection planned § Peer-reviewed publication demonstrating saliva testing sensitivity opens door for asymptomatic testing New York,...
Todos Medical Announces Preprint of Acute COVID-19 Paxlovid Rebound Rescued by Tollovid
01 août 2022 09h56 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Aug. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Partners with Amerimmune Diagnostics on Long COVID Biomarker Panel
28 juil. 2022 07h30 HE
|
Todos Medical Ltd.
NEW YORK, NY, AND TEL AVIV, ISRAEL, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Announces Preprint of Chronic Long COVID Case Study #8 of Paxlovid® Treatment Followed by Tollovid™ Dietary Supplementation
22 juil. 2022 09h33 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, July 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Reports Case Study #7 in Acute and Long COVID
12 juil. 2022 09h40 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, July 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Announces Positive Biomarker Data from Phase 2 Trial of Tollovir in Hospitalized COVID-19 Patients
30 juin 2022 07h51 HE
|
Todos Medical Ltd.
§ Biomarker data correlates with clinical data announced in January 2022 § 46 patient open label extension being opened to support US FDA EUA application New York, NY, and Tel Aviv, ISRAEL,...